Pharmaceutical intermediates 5-(4-Bromophenyl)-4,6-dichloropyrimidine CAS 146533-41-7
The trade name of macitentan is opsumit. It is an oral dual antagonist of ETA and ETB developed by actelionpharm, Switzerland. In October 2013, it was approved by FDA for the treatment of pulmonary chemicalbook hypertension, pulmonary fibrosis and other diseases. Since the listing of the commodity, its effectiveness, safety and tolerance have been good, and the market prospect is promising. 5 - (4-bromophenyl) - 4,6-dichloropyrimidine is one of the intermediates of maxitetan, which is mainly used for the preparation of maxitetan.
Synonyms:
PyriMidine,5-(4-broMophenyl)-4,6-dichloro-;5-(4-broMophenyl)-4,6-dichloropyriMidine;5-(4-Bromophenyl)-4,6-dichloro-Pyrimidin;5-(4-broMopheChemicalbooknyl)-4;MacitentanIntermediate1;5-(4-Bromophenyl)-4,6-dichloropyrimidine(146533-41-7);MacitentanImpurity26;potassiuM(N-propylsulfaMoyl)aMide
Application:
5-(4-Bromophenyl)-4,6-dichloropyrimidine is one of the intermediates of maxitetan, which is mainly used for the preparation of maxitetan.
Company overview
Analysis room and laboratory
Certificate of Patent
Management system certificate
Our Team
Packaging and Shipping
If you are interested in the product, contact 2bvideo.com for more information for more information
The information of 2bvideo.com limited shown above is provided by the user or collected on the network. Video 2B does not guarantee the authenticity,accuracy and legitimacy of 2bvideo.com limited information. Video 2B does not involve legal relationships and disputes between users arising from transactions other than secured transactions on this website. Disputes shall be settled by you through negotiation. If you are the person in charge or relevant employee of this enterprise, if you find that the enterprise information is incorrect or want to manage thiscompany, please contact us jacklee1558@gmail.com, after you claim the enterprise, you can obtain management permission, publish supplyand demand information, bring consulting orders, and remove page advertisements.